Merck (MRK) says it sees Terns (TERN) deal hurting EPS by USD 0.17 in the first 12 months

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

[CALENDER ADDITION] US Interior Secretary Burgum to address oil executives at 09:40EDT / 13:40GMT

German Chancellor Merz says the best way to combat high prices is to end the war in Iran; cannot cover all the additional costs from the federal budget

Merck (MRK) says it sees Terns (TERN) deal hurting EPS by USD 0.17 in the first 12 months

Bank of Canada resumes market operations; will proceed with its regular schedule for market operations, including today's AM auctions of receiver general balances

Hezbollah Chief says fighters are determined to continue without limits

On the Newsquawk feed at , 20 minutes before this page.

Use the PlatformFree. No signup, no card.

Context

Merck's announcement regarding the Terns deal indicating an EPS hit of USD 0.17 within the first year suggests a negative short-term outlook that could weigh on investor sentiment. This adjustment may prompt a reassessment of Merck's earnings trajectory and valuation by analysts, potentially impacting its share price and the broader pharmaceutical sector in conjunction. Keep an eye on how this affects market sentiment towards similar biotech deals and the overall stock.

Related headlines

The feed had this first.

Use the Platform